Evidence map›Paper›PMID 39204840›Full record

ReviewSensors (Basel, Switzerland)2024

Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges.

Mohamed Hemdan, Mohamed A Ali, Ahmed S Doghish, Sherif S Abdel Mageed, Ibrahim M Elazab, Magdy M Khalil, Mostafa Mabrouk, Diganta B Das, Alaa S Amin

Abstract readReview
In one paragraph

Review in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Nitrogen-doped carbon nanodots as a biocompatible FRET donor for caspase-3 detection and chemotherapy response evaluation in osteosarcoma cell lysates.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohamed HemdanSchool of Biotechnology, Badr University in Cairo (BUC), Badr City 11829, Egypt.
Mohamed A AliSchool of Biotechnology, Badr University in Cairo (BUC), Badr City 11829, Egypt.ORCID 0000-0002-7390-8592
Ahmed S DoghishDepartment of Biochemistry, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City 11829, Egypt.ORCID 0000-0002-0136-7096
Sherif S Abdel MageedPharmacology and Toxicology Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City 11829, Egypt.ORCID 0000-0003-0702-5035
Ibrahim M ElazabDepartment of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
Magdy M KhalilMedical Biophysics, Department of Physics, Faculty of Science, Helwan University, Cairo 11795, Egypt.
Mostafa MabroukRefractories, Ceramics and Building Materials Department, National Research Centre, 33 El Bohouth St., Giza 12622, Egypt.ORCID 0000-0003-3330-6762
Diganta B DasDepartment of Chemical Engineering, Loughborough University, Loughborough LE11 3TU, UK.ORCID 0000-0001-9427-6582
Alaa S AminChemistry Department, Faculty of Science, Benha University, Benha 13511, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This comprehensive review delves into the forefront of biosensor technologies and their critical roles in disease biomarker detection and therapeutic drug monitoring. It provides an in-depth analysis of various biosensor types and applications, including enzymatic sensors, immunosensors, and DNA sensors, elucidating their mechanisms and specific healthcare applications. The review highlights recent innovations such as integrating nanotechnology, developing wearable devices, and trends in miniaturisation, showcasing their transformative potential in healthcare. In addition, it addresses significant sensitivity, specificity, reproducibility, and data security challenges, proposing strategic solutions to overcome these obstacles. It is envisaged that it will inform strategic decision-making, drive technological innovation, and enhance global healthcare outcomes by synthesising multidisciplinary insights.

Indexed as

Biosensing TechniquesDrug MonitoringBiomarkersDelivery of Health CareHumansNanotechnologyWearable Electronic DevicesBiomarkersbiosensorsdisease biomarker detectionhealthcare applicationsnanotechnology integrationtherapeutic drug monitoring

Identifiers

PMID39204840
PMCPMC11360123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.